Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.20.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 9,308 $ 12,123
Premium and trade receivables 11,304 6,247
Short-term investments 1,386 863
Other current assets 2,698 1,090
Total current assets 24,696 20,323
Long-term investments 10,521 7,717
Restricted deposits 1,014 658
Property, software and equipment, net 2,439 2,121
Goodwill 17,417 6,863
Intangible assets, net 8,898 2,063
Other long-term assets 1,446 1,249
Total assets 66,431 40,994
Current liabilities:    
Medical claims liability 11,413 7,473
Accounts payable and accrued expenses 8,531 4,164
Return of premium payable 1,052 824
Unearned revenue 526 383
Current portion of long-term debt 129 88
Total current liabilities 21,651 12,932
Long-term debt 17,150 13,638
Other long-term liabilities 3,938 1,732
Total liabilities 42,739 28,302
Commitments and contingencies
Redeemable noncontrolling interests 36 33
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 594,890 issued and 579,122 outstanding at March 31, 2020, and 421,508 issued and 415,048 outstanding at December 31, 2019 0 0
Additional paid-in capital 19,279 7,647
Accumulated other comprehensive earnings (loss) (5) 134
Retained earnings 5,030 4,984
Treasury stock, at cost (15,768 and 6,460 shares, respectively) (755) (214)
Total Centene stockholders’ equity 23,549 12,551
Nonredeemable Noncontrolling interest 107 108
Total stockholders’ equity 23,656 12,659
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 66,431 $ 40,994